ArticlemBio2018
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
Caroline S Foo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this papercites it
ArticlemBio2018
Caroline S Foo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.